Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. A Nuclear Imaging agent is a compound, usually based on a drug molecule, that includes a small amount of radioactive material, or radiotracer. Radiotracers generate a signal that can be detected by a gamma (SPECT) camera or a positron emission tomography (PET) scanner. GlobalData uses proprietary data and analytics to provide a comprehensive report on the nuclear imaging agents devices market, including market shares of different players within the Netherlands. Buy the latest report here.
In 2021, GlobalData’s Market Model methodology determined that the leading player in the nuclear imaging agents market in the Netherlands was GE Healthcare followed by Bracco Diagnostics, Cardinal Health, Advanced Accelerator Applications and Lantheus.
PET Imaging Agents includes Copper-Based PET Imaging Agents, Fluorine-Based PET Imaging Agents, Gallium-68-Based PET Imaging Agents and Rubidium-Based PET Imaging Agents. SPECT Imaging Agents includes Indium-Based SPECT Imaging Agents, Iodine-Based SPECT Imaging Agents, Lutetium-Based SPECT Imaging Agents, Technetium-Based SPECT Imaging Agents and Thallium-Based SPECT Imaging Agents.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the nuclear imaging agents devices market within the Netherlands was expected to be over $7m in 2021.
For the latest complete market share analysis of nuclear imaging agents device market in the Netherlands, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.